Nucleate Podcast

Nucleate
  • 5.0 (3)
  • TECHNOLOGY
Nucleate Podcast

Nucleate is the new voice for next generation biotech leaders.

  1. 3D AGO

    Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC

    Nucleate Podcast

    1h 17m

  2. MAR 5

    Rewriting Genetic Medicine with Epigenetic Editing | Dr Catherine Stehman-Breen, former CEO of Chroma Medicine

    Dr. Catherine Stehman-Breen discusses her career journey, from her early interest in medicine to her roles at pharmaceutical companies like Amgen. The highlight is her time as CEO of Chroma Medicine, a biotech focused on epigenetic editing.

    1h 20m

  3. FEB 5

    Revolutionizing Gene Therapy with AI | Eric Kelsic, Dyno Tx

    Nucleate Podcast

    57 min

  4. JAN 22

    From Sequencing the Human Genome to Venture Capital | Peter Barrett, Atlas Venture

    Nucleate Podcast

    1h 5m

  5. JAN 7

    Designing Programmable Genetic Medicines | Jake Becraft, Strand Therapeutics

    Nucleate Podcast

    52 min

  6. 12/08/2024

    The Vagina Business | Marina Gerner

    We are very excited to have Dr Marina Gerner joining us on the Nucleate Pocast to discuss her book called The Vagina Business. The Vagina Business has already been getting attention with grants from the Alfred P. Sloan Foundation and The Society of Authors. Kirkus Reviews has praised the book as "energetic, thoroughly engaging reading" and emphasized its potential to improve women's health outcomes worldwide. It has also been recommended as a must-read business book by the Financial Times. As a journalist, Marina has written about books and arts, as well as finance and tech for over a decade. Her range of expertise has led to Marina being called "a Renaissance woman of the modern age." ​Marina has won several awards and written for The Economist, Jewish Chronicle, Guardian, Financial Times, Wired, the Times Literary Supplement, The Times, and the Wall Street Journal. She has been a contributing editor at The Sunday Times Raconteur, the i newspaper and MoneyWeek. Before that she was a Staff Writer at Money Observer, where she wrote a column called “Marina’s Imaginary Millions.”​ She is an Adjunct Professor of Commerce & Culture at the NYU Stern School of Business (on their London campus) and she has a PhD from the London School of Economics, which was funded by merit-based scholarships.​

    41 min

  7. 11/19/2024

    The Art of the Pitch: Storytelling in Film and Biotech | Michael Langer, T.Rx Capital

    Michael Langer has had a diverse and fascinating career, with experience spanning startups, venture capital, biotech, filmmaking, and philanthropy. He was inspired from a young age by his father's work in the Langer Lab and early exposure to the startup world. Langer's background includes formative experiences like an impactful internship at Living Proof and taking time off from college to backpack internationally, which he credits with shaping his entrepreneurial mindset. Langer reflects on lessons learned from his time at Pear Therapeutics, particularly around navigating business models and regulatory risks in the digital health space. This experience has informed his approach to investing in tech bio companies at his new fund, T.Rx Capital. Throughout the conversation, Langer emphasizes the critical role of storytelling in entrepreneurship and investing, providing insights on how founders can effectively communicate their vision.

    37 min

  8. 11/03/2024

    Unlocking the power of the gut microbiome with AI | Leo Grady, Jona

    In this episode, Anastasia Janas interviews Leo Grady, founder and CEO of Jona. With over 20 years in AI and healthcare, Leo has made a profound impact on the field, including leading the development of the first FDA-approved AI system in pathology at Paige.AI. Together, they dive into the journey that led him to create Jona, a company focused on using AI to analyze the gut microbiome for personalized health insights. Leo shares his thoughts on AI's role in healthcare today, from emerging trends to its transformative potential in improving patient outcomes. Drawing on his own experience building Jona, he offers practical advice for those looking to enter healthcare AI, touching on the unique challenges and opportunities in biotech. With over 100 peer-reviewed papers and 300 patents to his name, Leo’s contributions to AI-driven healthcare are significant. This episode is packed with insights and inspiration for anyone interested in the future of healthcare innovation!

    45 min
See All (21)

    Ratings & Reviews

    5
    out of 5
    3 Ratings

    About

    Nucleate is the new voice for next generation biotech leaders.

    Information

    • Creator
      Nucleate
    • Years Active
      2023 - 2025
    • Episodes
      21
    • Rating
      Clean
    • Copyright
      © 2024 Nucleate Podcast
    • Show Website
      Nucleate Podcast

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.
    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada